本文選題：心肌梗死 + 經(jīng)皮冠狀動脈介入　； 參考：《山東醫(yī)藥》2017年33期

【摘要】：目的探討血清胱抑素C(cysC)水平對急性非ST段抬高型心肌梗死(NSTEMI)經(jīng)皮冠狀動脈介入(PCI)患者預(yù)后的影響。方法選取NSTEMI并且行PCI治療患者331例,根據(jù)血清cysC水平將患者分為cysC低水平組(cysC≤1.385 mg/L)243例、cysC高水平組(cysC1.385 mg/L)88例。PCI治療后隨訪12~68個月,收集兩組臨床資料,記錄兩組心血管不良事件及預(yù)后情況,通過COX回歸分析研究血清cysC水平對患者預(yù)后的影響。結(jié)果與cysC低水平組比較,cysC高水平組年齡較大、血清肌酐水平較高、高血壓比例較高(P均0.05)。cysC高水平組較低水平組PCI術(shù)后全因病死和心源性病死發(fā)生率高(P均0.05),cysC水平升高是NSTEMI患者PCI術(shù)后發(fā)生全因病死及心源性病死的獨立預(yù)測因素。結(jié)論 cysC水平升高對NSTEMI患者PCI治療患者預(yù)后具有預(yù)測價值。
[Abstract]:Objective to investigate the effect of serum cystatin cysC on the prognosis of patients with nonST-segment elevation myocardial infarction (NSTEMI) with percutaneous coronary intervention (PCI). Methods three hundred and thirty-one patients with NSTEMI were selected and treated with PCI. According to the level of serum cysC, the patients were divided into two groups: the low cysC group with cysC 鈮，

本文編號：1876860